{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:22:31Z","timestamp":1756902151200,"version":"3.44.0"},"reference-count":18,"publisher":"The Pediatric Pharmacy Association","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"abstract":"<jats:p>Atopic dermatitis is considered an important risk factor for chronic hand dermatitis, which can be seen in children too. Pimecrolimus cream 1% is approved to treat atopic dermatitis in children aged 2 years or older. In adults, this drug has been used for some clinical indications other than atopic dermatitis, such as chronic hand dermatitis. Here, we describe an adverse drug reaction in a 2-year-old child affected with atopic dermatitis, who was treated with topical pimecrolimus in order to ameliorate her concomitant hand dermatitis. The use of topical pimecrolimus led to a previously undescribed hand pustular dermatosis, being consistent with a form of pustular leukocytoclastic vasculitis, which required the permanent discontinuation of topical pimecrolimus.<\/jats:p>","DOI":"10.5863\/1551-6776-21.1.81","type":"journal-article","created":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T21:23:41Z","timestamp":1457040221000},"page":"81-84","source":"Crossref","is-referenced-by-count":1,"title":["Acute Pustular Dermatosis, Following Topical Treatment With Pimecrolimus, in a Child Affected With Atopic and Contact Hand Dermatitis"],"prefix":"10.5863","volume":"21","author":[{"given":"Dimitri","family":"Poddighe","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Azienda Ospedaliera di Melegnano, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Brazzelli","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Fondazione IRCCS Policlinico San Matteo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelia","family":"Licari","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Fondazione IRCCS Policlinico San Matteo\u2013Universita' degli Studi, Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Luigi","family":"Marseglia","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Fondazione IRCCS Policlinico San Matteo\u2013Universita' degli Studi, Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3883","reference":[{"issue":"5","key":"i1551-6776-21-1-81-b1","series-title":"Contact Dermatitis","first-page":"257","article-title":"Classification of atopic hand eczema and filaggrin mutations","volume":"59","year":"2008","unstructured":"Giwercman\n              C\n            , LerbaekA, BisgaardH, Menn\u00e9T.\n          Classification of atopic hand eczema and filaggrin mutations. Contact Dermatitis. 2008;59(5):257\u2013260."},{"issue":"2","key":"i1551-6776-21-1-81-b2","series-title":"Pediatr Dermatol","first-page":"102","article-title":"Clinical evaluation of atopic hand-foot dermatitis","volume":"18","year":"2001","unstructured":"Lee\n              HJ\n            , HASJ, AhnWK, \n          et al. Clinical evaluation of atopic hand-foot dermatitis. Pediatr Dermatol. 2001;18(2):102\u2013106."},{"issue":"2","key":"i1551-6776-21-1-81-b3","series-title":"Dermatology","first-page":"119","article-title":"Patch tests in children with suspected allergic contact dermatitis: a prospective study and review of the literature","volume":"218","year":"2009","unstructured":"de Waard-van der Spek\n              FB\n            , OranjeAP.\n          Patch tests in children with suspected allergic contact dermatitis: a prospective study and review of the literature. Dermatology. 2009;218(2):119\u2013125."},{"issue":"5","key":"i1551-6776-21-1-81-b4","series-title":"Acta Derm Venereol","first-page":"583","article-title":"Children with atopic dermatitis should always be patch tested if they have hand or foot dermatitis","volume":"95","year":"2015","unstructured":"Isaksson\n              M\n            , OlhardtS, RadehedJ, SvenssonA.\n          Children with atopic dermatitis should always be patch tested if they have hand or foot dermatitis. Acta Derm Venereol. 2015;95(5):583\u2013586."},{"issue":"6","key":"i1551-6776-21-1-81-b5","series-title":"Eur J Dermatol","first-page":"758","article-title":"Recommendations for pimecrolimus 1% cream in the treatment of mild to moderate atopic dermatitis: from medical needs to a new treatment algorithm","volume":"23","year":"2013","unstructured":"Luger\n              T\n            , De RaeveL, GelmettiC, \n          et al. Recommendations for pimecrolimus 1% cream in the treatment of mild to moderate atopic dermatitis: from medical needs to a new treatment algorithm. Eur J Dermatol. 2013;23(6):758\u2013766."},{"issue":"3","key":"i1551-6776-21-1-81-b6","series-title":"Am J Clin Dermatol","first-page":"157","article-title":"The role of topical calcineurin inhibitors for skin diseases other than atopic dermatitis","volume":"8","year":"2007","unstructured":"Wollina\n              U.\n            \n          \n          The role of topical calcineurin inhibitors for skin diseases other than atopic dermatitis. Am J Clin Dermatol. 2007;8(3):157\u2013173."},{"issue":"4","key":"i1551-6776-21-1-81-b7","series-title":"Pediatr Allergy Immunol","first-page":"306","article-title":"Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants","volume":"26","year":"2015","unstructured":"Luger\n              T\n            , BoguniewiczM, CarrW, \n          et al. Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants. Pediatr Allergy Immunol. 2015;26(4):306\u2013315."},{"issue":"4","key":"i1551-6776-21-1-81-b8","series-title":"Pediatrics","first-page":"597","article-title":"Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trial","volume":"135","year":"2015","unstructured":"Sigurgeirsson\n              B\n            , BoznanskiA, ToddG, \n          et al. Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trial. Pediatrics. 2015;135(4):597\u2013606."},{"issue":"6","key":"i1551-6776-21-1-81-b9","series-title":"JAMA Dermatol","first-page":"594","article-title":"Association between malignancy and topical use of pimecrolimus","volume":"151","year":"2015","unstructured":"Margolis\n              DJ\n            , AbuabaraK, HoffstadOJ, \n          et al. Association between malignancy and topical use of pimecrolimus. JAMA Dermatol. 2015;151(6):594\u2013599."},{"key":"i1551-6776-21-1-81-b10","series-title":"Cutis","first-page":"31","article-title":"Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis","volume":"73","year":"2004","unstructured":"Belsito\n              DV\n            , FowlerJFJr, MarksJGJr, \n          et al. Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis. Cutis. 2004;73:31\u201338."},{"issue":"1","key":"i1551-6776-21-1-81-b11","series-title":"Dermatology","first-page":"71","article-title":"Efficacy and safety of pimecrolimus cream 1% in mild-to-moderate chronic hand dermatitis: a randomized, double-blind trial","volume":"221","year":"2010","unstructured":"Hordinsky\n              M\n            , FleischerA, RiversJK, \n          et al. Efficacy and safety of pimecrolimus cream 1% in mild-to-moderate chronic hand dermatitis: a randomized, double-blind trial. Dermatology. 2010;221(1):71\u201377."},{"issue":"5","key":"i1551-6776-21-1-81-b12","series-title":"J Eur Acad Dermatol Venereol","first-page":"493","article-title":"Pimecrolimus: a review","volume":"17","year":"2003","unstructured":"Gupta\n              AK\n            , ChowM.\n          Pimecrolimus: a review. J Eur Acad Dermatol Venereol. 2003;17(5):493\u2013503."},{"issue":"2","key":"i1551-6776-21-1-81-b13","series-title":"J Pediatr","first-page":"155","article-title":"Safety and efficacy of non steroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants","volume":"142","year":"2003","unstructured":"Ho\n              VC\n            , GuptaA, KaufmannR, \n          et al. Safety and efficacy of non steroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants. J Pediatr. 2003;142(2):155\u2013162."},{"issue":"6","key":"i1551-6776-21-1-81-b14","series-title":"Contact Dermatitis","first-page":"354","article-title":"Allergic contact dermatitis from oleyl alcohol in Elidel cream","volume":"55","year":"2006","unstructured":"Andersen\n              KE\n            , Broesby-OlsenS.\n          Allergic contact dermatitis from oleyl alcohol in Elidel cream. Contact Dermatitis. 2006;55(6):354\u2013356."},{"issue":"4","key":"i1551-6776-21-1-81-b15","series-title":"J Am Acad Dermatol","first-page":"767","article-title":"New insights into pustular dermatoses in pediatric patients","volume":"70","year":"2014","unstructured":"Posso-De Los Rios\n              CJ\n            , PopeE.\n          New insights into pustular dermatoses in pediatric patients. J Am Acad Dermatol. 2014;70(4):767\u2013773."},{"issue":"3","key":"i1551-6776-21-1-81-b16","series-title":"Clin Dermatol","first-page":"376","article-title":"Neutrophilic dermatoses as systemic diseases","volume":"32","year":"2014","unstructured":"Prat\n              L\n            , BouazizJD, WallachD, \n          et al. Neutrophilic dermatoses as systemic diseases. Clin Dermatol. 2014;32(3):376\u2013388."},{"issue":"5","key":"i1551-6776-21-1-81-b17","series-title":"Transplantation","first-page":"739","article-title":"Sirolimus-induced leukocytoclastic vasculitis","volume":"74","year":"2002","unstructured":"Hardinger\n              K\n            , CorneliusL, TrulockEP, BrennanDC.\n          Sirolimus-induced leukocytoclastic vasculitis. Transplantation. 2002;74(5):739\u2013740."},{"issue":"2","key":"i1551-6776-21-1-81-b18","series-title":"Clin Pharmacol Ther","first-page":"239","article-title":"A method for estimating the probability of adverse drug reaction","volume":"30","year":"1981","unstructured":"Naranjo\n              CA\n            , BustoU, SellersEM, \n          et al. A method for estimating the probability of adverse drug reaction. Clin Pharmacol Ther. 1981;30(2):239\u2013245."}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/21\/1\/article-p81.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/jppt\/article-pdf\/21\/1\/81\/1786520\/1551-6776-21_1_81.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/21\/1\/article-p81.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/21\/1\/article-p81.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:41:29Z","timestamp":1747356089000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/21\/1\/article-p81.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":18,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-21.1.81","relation":{},"ISSN":["1551-6776"],"issn-type":[{"type":"print","value":"1551-6776"}],"subject":[],"published":{"date-parts":[[2016]]}}}